Rødningen Olaug Kristin, Børresen-Dale Anne-Lise, Alsner Jan, Hastie Trevor, Overgaard Jens
Department of Genetics, Institute of Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo, Norway.
Radiother Oncol. 2008 Mar;86(3):314-20. doi: 10.1016/j.radonc.2007.09.013. Epub 2007 Oct 25.
BACKGROUND AND PURPOSE: Breast cancer patients show a large variation in normal tissue reactions after ionizing radiation (IR) therapy. One of the most common long-term adverse effects of ionizing radiotherapy is radiation-induced fibrosis (RIF), and several attempts have been made over the last years to develop predictive assays for RIF. Our aim was to identify basal and radiation-induced transcriptional profiles in fibroblasts from breast cancer patients that might be related to the individual risk of RIF in these patients. MATERIALS AND METHODS: Fibroblast cell lines from 31 individuals with variable risk of RIF (grouped into five classes from low to high risk) were irradiated with two different schemes: 1 x 3.5 Gy with RNA isolated 2 and 24h after irradiation, and a fractionated scheme with 3 x 3.5 Gy in intervals of 24h with RNA isolated 2h after the last dose. RNA was also isolated from non-treated fibroblasts. Transcriptional differences in basal and radiation-induced gene expression profiles were investigated using 15K cDNA microarrays, and results analyzed by both SAM and PAM. RESULTS: Sixty differentially expressed genes were identified by applying SAM on 10 patients with the highest risk of RIF and the four patients with the lowest risk of RIF after the fractionated scheme. The genes were associated with known functions in processes like apoptosis, extracellular matrix remodelling/cell adhesion, proliferation and ROS scavenging. A minimum set of 18 genes were identified that could differentiate high risk from low risk-patients after the fractionated scheme. CONCLUSIONS: The classifier of 18 genes may provide basis for a predictive assay for normal tissue reactions after radiotherapy, and provide new insight into the molecular mechanisms of RIF.
背景与目的:乳腺癌患者在电离辐射(IR)治疗后正常组织反应存在很大差异。电离放射治疗最常见的长期不良反应之一是放射性纤维化(RIF),在过去几年中已经进行了几次尝试来开发RIF的预测检测方法。我们的目的是确定乳腺癌患者成纤维细胞中基础和辐射诱导的转录谱,这些转录谱可能与这些患者个体发生RIF的风险相关。 材料与方法:来自31名RIF风险各异的个体(分为从低到高风险的五类)的成纤维细胞系,采用两种不同方案进行照射:单次3.5 Gy照射,分别在照射后2小时和24小时分离RNA;分次照射方案,每次3.5 Gy,间隔24小时,共3次,在最后一次剂量后2小时分离RNA。同时也从未经处理的成纤维细胞中分离RNA。使用15K cDNA微阵列研究基础和辐射诱导的基因表达谱中的转录差异,并通过SAM和PAM分析结果。 结果:通过对分次照射方案后RIF风险最高的10名患者和风险最低的4名患者应用SAM,鉴定出60个差异表达基因。这些基因与凋亡、细胞外基质重塑/细胞黏附、增殖和ROS清除等过程中的已知功能相关。确定了一组最少18个基因,这些基因可以在分次照射方案后区分高风险和低风险患者。 结论:18个基因的分类器可为放疗后正常组织反应的预测检测提供基础,并为RIF的分子机制提供新的见解。
Int J Radiat Biol. 2002-3
Int J Radiat Oncol Biol Phys. 2006-12-1
Cell Commun Signal. 2025-3-20
Cell Death Dis. 2023-8-22
Cancers (Basel). 2022-12-19